CTN-0069-A-2: The Impact of COVID-19 on Individuals with Opioid Use Disorder Who Received Emergency Department Care: A Survey Study of Project ED Health Participants and Medical Leadership at Four EDs

Jennifer Edelman, MD, MHS
Lead Investigator

Yale School of Medicine

This study leverages the Project ED Health study (CTN-0069) to assess the impact of the COVID-19 epidemic on opioid use and treatment and COVID-19 symptoms and testing. Specifically, the investigators seek to characterize the impact of the COVID-19 pandemic on (Aim 1) OUD treatment (engagement and access to MOUD), drug use, drug supply, and overdose risk, (Aim 2) COVID-19 related symptoms and testing, and (Aim 3) ED leadership reports of the presentation of patients with OUD to the ED, ED-based buprenorphine prescribing practices, and community treatment options.

    Node Involvement

    Lead Node(s):

  • New England Consortium

  • All Participating Nodes:

  • New England Consortium